Detalhe da pesquisa
1.
Impact of muscle biopsy on the clinical decision-making process in patients with suspected idiopathic inflammatory myopathy.
J Autoimmun
; 144: 103185, 2024 04.
Artigo
Inglês
| MEDLINE | ID: mdl-38428109
2.
Multiparametric Prediction Models for Coronavirus Disease 2019 Vaccine Selection: Results of a Comparative Population-Based Cohort Study.
Clin Infect Dis
; 76(5): 816-823, 2023 03 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36328594
3.
Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls.
Ann Rheum Dis
; 82(2): 292-300, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36109141
4.
Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases.
J Autoimmun
; 135: 102981, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36706534
5.
Viewpoint: how to measure comorbidities in patients with rheumatoid arthritis - clinical and academic value.
Rheumatology (Oxford)
; 62(SI3): SI282-SI285, 2023 10 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37871917
6.
Preanalytical stability of SARS-CoV-2 anti-nucleocapsid antibodies.
Clin Chem Lab Med
; 61(2): 332-338, 2023 01 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36323338
7.
Trajectory clusters of radiographic progression in patients with rheumatoid arthritis: associations with clinical variables.
Ann Rheum Dis
; 81(2): 175-183, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34376384
8.
Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial.
Ann Rheum Dis
; 81(6): 838-844, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35210264
9.
Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study.
Ann Rheum Dis
; 81(7): 1017-1022, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35304407
10.
Importance of the second SARS-CoV-2 vaccination dose for achieving serological response in patients with rheumatoid arthritis and seronegative spondyloarthritis.
Ann Rheum Dis
; 81(3): 416-421, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34844927
11.
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial.
Ann Rheum Dis
; 81(5): 687-694, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35027397
12.
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study.
Ann Rheum Dis
; 81(12): 1750-1756, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35977809
13.
SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity.
Ann Rheum Dis
; 80(10): 1345-1350, 2021 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34285048
14.
Predictors of successful discontinuation of biologic and targeted synthetic DMARDs in patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review.
Rheumatology (Oxford)
; 59(2): 324-334, 2020 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31325305
15.
Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries.
Ann Rheum Dis
; 78(11): 1472-1479, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31427438
16.
Comorbidity burden in axial spondyloarthritis: a cluster analysis.
Rheumatology (Oxford)
; 58(10): 1746-1754, 2019 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31220322
17.
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis.
Ann Rheum Dis
; 77(4): 476-479, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29301783
18.
Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohorts.
Clin Exp Rheumatol
; 36(3): 362-370, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29533752
19.
Low rates of biologic-free clinical disease activity index remission maintenance after biologic disease-modifying anti-rheumatic drug discontinuation while in remission in a Japanese multicentre rheumatoid arthritis registry.
Rheumatology (Oxford)
; 55(2): 286-90, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26350484
20.
The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs.
Rheumatology (Oxford)
; 54(11): 2076-84, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26163688